These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 12907464

  • 1. Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells.
    Ghiselli G, Chen J, Kaou M, Hallak H, Rubin R.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1808-13. PubMed ID: 12907464
    [Abstract] [Full Text] [Related]

  • 2. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC, Rahimi N, Forsten-Williams K, Nugent MA.
    Circ Res; 2004 Feb 20; 94(3):316-23. PubMed ID: 14684627
    [Abstract] [Full Text] [Related]

  • 3. Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells.
    Pardo OE, Arcaro A, Salerno G, Tetley TD, Valovka T, Gout I, Seckl MJ.
    Oncogene; 2001 Nov 15; 20(52):7658-67. PubMed ID: 11753643
    [Abstract] [Full Text] [Related]

  • 4. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL, Lu GH, Dahring TK, Batley BL, Connolly C, Hamby JM, Brown KJ.
    J Pharmacol Exp Ther; 1998 Jul 15; 286(1):569-77. PubMed ID: 9655904
    [Abstract] [Full Text] [Related]

  • 5. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M.
    Circulation; 2003 Nov 25; 108(21):2679-88. PubMed ID: 14623816
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X, Weng LP, Yu Q.
    Oncogene; 2000 May 04; 19(19):2346-53. PubMed ID: 10822386
    [Abstract] [Full Text] [Related]

  • 7. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M, Wirz W, Tag CG, Mavituna M, Emans N, Korff T, Stoldt V, Gressner AM, Kiefer P.
    Growth Factors; 2005 Jun 04; 23(2):87-95. PubMed ID: 16019430
    [Abstract] [Full Text] [Related]

  • 8. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J.
    Clin Cancer Res; 2005 Apr 01; 11(7):2702-12. PubMed ID: 15814652
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells.
    Nakahara T, Sato H, Shimizu T, Tanaka T, Matsui H, Kawai-Kowase K, Sato M, Iso T, Arai M, Kurabayashi M.
    Biochem Biophys Res Commun; 2010 Apr 02; 394(2):243-8. PubMed ID: 19903460
    [Abstract] [Full Text] [Related]

  • 10. The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production.
    Okazaki J, Mawatari K, Liu B, Kent KC.
    Surgery; 2000 Aug 02; 128(2):192-7. PubMed ID: 10922991
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration.
    Mii S, Ware JA, Kent KC.
    Surgery; 1993 Aug 02; 114(2):464-70. PubMed ID: 8393599
    [Abstract] [Full Text] [Related]

  • 12. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
    Geraldes P, Sirois MG, Tanguay JF.
    Circ Res; 2003 Sep 05; 93(5):399-405. PubMed ID: 12893737
    [Abstract] [Full Text] [Related]

  • 13. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
    Bansal R, Magge S, Winkler S.
    J Neurosci Res; 2003 Nov 15; 74(4):486-93. PubMed ID: 14598292
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK, Lu GH, Hamby JM, Batley BL, Kraker AJ, Panek RL.
    J Pharmacol Exp Ther; 1997 Jun 15; 281(3):1446-56. PubMed ID: 9190882
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
    Banes A, Florian JA, Watts SW.
    J Pharmacol Exp Ther; 1999 Dec 15; 291(3):1179-87. PubMed ID: 10565840
    [Abstract] [Full Text] [Related]

  • 16. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
    Religa P, Kazi M, Thyberg J, Gaciong Z, Swedenborg J, Hedin U.
    Eur J Vasc Endovasc Surg; 2000 Nov 15; 20(5):419-26. PubMed ID: 11112459
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.
    Skaletz-Rorowski A, Pinkernell K, Sindermann JR, Schriever C, Müller JG, Eschert H, Breithardt G.
    Basic Res Cardiol; 2004 Jul 15; 99(4):272-8. PubMed ID: 15221345
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor-1-induced ERK1/2 signaling reciprocally regulates proliferation and smooth muscle cell differentiation of ligament-derived endothelial progenitor cell-like cells.
    Takahashi M, Okubo N, Chosa N, Takahashi N, Ibi M, Kamo M, Mizuki H, Ishisaki A, Kyakumoto S.
    Int J Mol Med; 2012 Mar 15; 29(3):357-64. PubMed ID: 22108586
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
    Segev A, Aviezer D, Safran M, Gross Z, Yayon A.
    Cardiovasc Res; 2002 Jan 15; 53(1):232-41. PubMed ID: 11744033
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.
    Li G, Oparil S, Kelpke SS, Chen YF, Thompson JA.
    Circulation; 2002 Aug 13; 106(7):854-9. PubMed ID: 12176960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.